4th Quarter - Report — AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN (2011)

Firm

AMERICAN CLINICAL LABORATORY ASSN

Client

AMERICAN CLINICAL LABORATORY ASSN

Income

—

Expenses

$160,000

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule; HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control ACt of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 3630, the Temporary Payroll Tax Cut Continuation Act of 2011; HR 3765, the Temporary Payroll Tax Cut Continuation Act of 2011 (PL 112-78); Medicare laboratory co-insurance and co-payments

Lobbyist	Covered position, as disclosed
JASON DUBOIS	Vice President, Government Relations
JO ANNE GLISSON	Senior Vice President
JENNIFER BULLARD MADSEN	Vice President, Policy and Regulatory Affairs
ALAN MERTZ	President
DAVID ALAN MONGILLO	Vice President, Policy and Medical Affairs
FRANCESCA FIERRO O'REILLY	Vice President, Government Relations

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 3630 (112th), H.R. 3207 (112th), H.R. 3765 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.